Price Alert

Medifast Inc. (MED)

NYSE: MED · Real-Time Price · USD

13.16

0.13 (1.00%)

At close: Aug 15, 2025, 9:57 AM

Medifast Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	105.56M	115.73M	119M	140.16M	168.56M	174.74M	191.01M	235.87M	296.19M	348.98M	337.25M	390.4M	453.33M	417.6M	377.83M	413.39M	394.19M	340.67M
Cost of Revenue	28.91M	31.48M	30.78M	34.49M	45.12M	47.45M	49.65M	58.49M	85.47M	102.59M	103.65M	107.55M	131.65M	115.31M	99.55M	106.34M	100.48M	92.12M
Gross Profit	76.64M	84.25M	88.22M	105.67M	123.44M	127.29M	141.37M	177.38M	210.72M	246.39M	233.6M	282.85M	321.68M	302.29M	278.29M	307.06M	293.71M	248.55M
Operating Income	-1.07M	-1.26M	709K	2.11M	-7.88M	7.94M	8.68M	25.51M	38.71M	53.51M	32.6M	48.16M	48.96M	55.09M	46.84M	55.17M	61.43M	52.8M
Interest Income	1.37M	1.3M	953K	1.33M	1.3M	n/a	1.18M	1.03M	462K	n/a	182K	n/a	n/a	n/a	n/a	n/a	n/a	23K
Pretax Income	2.88M	526K	1.27M	1.58M	-10.65M	11.59M	9.8M	26.55M	39.12M	53.33M	32.41M	47.88M	48.8M	54.98M	46.75M	55.19M	61.34M	52.84M
Net Income	2.48M	-772K	800K	1.13M	-8.15M	8.32M	6.04M	23.13M	30.28M	39.97M	26.52M	36.16M	39.11M	41.78M	34.02M	41.98M	46.96M	41.06M
Selling & General & Admin	77.71M	84.51M	86.21M	102.47M	130.21M	118.35M	132.69M	151.87M	172.01M	192.88M	201M	234.69M	272.72M	247.2M	231.45M	251.89M	232.27M	195.75M
Research & Development	n/a	n/a	n/a	n/a	1.1M	1M	1.2M	1.3M	1.1M	1M	1.2M	1.1M	1.2M	900K	1.1M	1.2M	1.1M	1M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-50K	7K	-51K	-1K	-9K	-17K	-4K	-16K	7K	115K	-22K	19K
Operating Expenses	77.71M	85.51M	87.51M	103.57M	131.31M	119.35M	132.69M	151.87M	172.01M	192.88M	201M	234.69M	272.72M	247.2M	231.45M	251.89M	232.27M	195.75M
Interest Expense	n/a	n/a	n/a	n/a	n/a	1.22M	n/a	n/a	n/a	181K	181K	261K	164K	95K	93K	94K	67K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	3.4M	n/a	n/a	n/a	1.7M	n/a	n/a	n/a	1.6M	n/a	n/a	n/a
Cost & Expenses	106.62M	116.99M	118.29M	138.06M	176.43M	166.8M	182.34M	210.36M	257.48M	295.47M	304.65M	342.24M	404.37M	362.51M	331M	358.22M	332.75M	287.87M
Income Tax Expense	395K	1.3M	474K	449K	-2.5M	3.27M	3.77M	3.42M	8.84M	13.36M	5.89M	11.72M	9.68M	13.2M	12.73M	13.21M	14.38M	11.78M
Shares Outstanding (Basic)	10.99M	10.95M	10.93M	10.94M	10.94M	10.91M	10.89M	10.89M	10.89M	10.86M	10.91M	10.96M	11.35M	11.56M	11.69M	11.69M	11.75M	11.77M
Shares Outstanding (Diluted)	11.06M	10.95M	10.96M	10.97M	10.94M	10.96M	10.94M	10.93M	10.92M	10.9M	10.99M	11.04M	11.44M	11.64M	11.79M	11.79M	11.86M	11.88M
EPS (Basic)	0.23	-0.07	0.07	0.10	-0.75	0.76	0.55	2.12	2.78	3.68	2.43	3.30	3.44	3.62	2.91	3.59	4.00	3.49
EPS (Diluted)	0.22	-0.07	0.07	0.10	-0.75	0.76	0.55	2.12	2.77	3.67	2.41	3.27	3.42	3.59	2.89	3.56	3.96	3.46
EBITDA	2.98M	2.02M	3.89M	5.3M	-4.81M	7.94M	12.03M	28.92M	42.07M	56.48M	36.9M	48.16M	51.69M	57.52M	49.88M	57.92M	64.04M	52.8M
EBIT	-1.07M	-1.26M	709K	2.11M	-7.88M	11.59M	9.8M	26.55M	39.12M	53.51M	32.59M	48.14M	48.96M	55.07M	46.84M	55.29M	61.41M	52.84M
Depreciation & Amortization	4.04M	3.28M	3.19M	3.19M	3.07M	4.37M	4.43M	4.43M	4.51M	4.34M	4.31M	4.38M	2.73M	2.44M	4.61M	2.63M	2.63M	2.01M